89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
7.80
-0.31 (-3.82%)
At close: May 13, 2025, 4:00 PM
7.80
0.00 (0.00%)
Pre-market: May 14, 2025, 6:57 AM EDT
89bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 315.4 | 126.06 | 316.16 | 55.26 | 52.43 | 98.18 | Upgrade
|
| Short-Term Investments | 323.38 | 313.9 | 262.71 | 132.91 | 98.29 | 106.45 | Upgrade
|
| Cash & Short-Term Investments | 638.78 | 439.96 | 578.87 | 188.16 | 150.72 | 204.63 | Upgrade
|
| Cash Growth | 13.60% | -24.00% | 207.65% | 24.84% | -26.35% | 119.24% | Upgrade
|
| Prepaid Expenses | 44.16 | 36.5 | 14.66 | 7.92 | 11.24 | 5.55 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 682.94 | 476.45 | 593.53 | 196.08 | 161.98 | 210.2 | Upgrade
|
| Property, Plant & Equipment | 1.49 | 1.6 | 2.34 | 0.46 | 0.15 | 0.17 | Upgrade
|
| Other Long-Term Assets | 0.59 | 0.64 | 0.4 | 0.29 | 0.29 | 0.71 | Upgrade
|
| Total Assets | 685.03 | 478.69 | 596.27 | 196.82 | 162.42 | 211.07 | Upgrade
|
| Accounts Payable | 14.79 | 15.38 | 8.59 | 12.5 | 6.84 | 2.07 | Upgrade
|
| Accrued Expenses | 22.34 | 20.02 | 20.53 | 11.94 | 10.19 | 6.05 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 2.5 | - | Upgrade
|
| Current Portion of Leases | 0.75 | 0.73 | 0.5 | 0.17 | - | - | Upgrade
|
| Total Current Liabilities | 37.88 | 36.13 | 29.61 | 24.61 | 19.54 | 8.11 | Upgrade
|
| Long-Term Debt | 35.94 | 35.73 | 24.8 | 20.19 | 16.9 | - | Upgrade
|
| Long-Term Leases | 0.89 | 1.09 | 1.82 | 0.19 | - | - | Upgrade
|
| Other Long-Term Liabilities | 4.86 | 4.95 | 3.74 | - | 0.03 | - | Upgrade
|
| Total Liabilities | 79.57 | 77.9 | 59.96 | 44.99 | 36.47 | 8.11 | Upgrade
|
| Common Stock | 0.15 | 0.12 | 0.09 | 0.05 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 1,501 | 1,225 | 993.46 | 467.37 | 339.22 | 326.05 | Upgrade
|
| Retained Earnings | -895.79 | -824.51 | -457.43 | -315.24 | -213.22 | -123.1 | Upgrade
|
| Comprehensive Income & Other | 0.39 | 0.56 | 0.19 | -0.35 | -0.06 | -0.01 | Upgrade
|
| Total Common Equity | 605.46 | 400.79 | 536.31 | 151.83 | 125.96 | 202.96 | Upgrade
|
| Shareholders' Equity | 605.46 | 400.79 | 536.31 | 151.83 | 125.96 | 202.96 | Upgrade
|
| Total Liabilities & Equity | 685.03 | 478.69 | 596.27 | 196.82 | 162.42 | 211.07 | Upgrade
|
| Total Debt | 37.58 | 37.55 | 27.11 | 20.55 | 19.4 | - | Upgrade
|
| Net Cash (Debt) | 601.2 | 402.41 | 551.76 | 167.61 | 131.32 | 204.63 | Upgrade
|
| Net Cash Growth | 12.38% | -27.07% | 229.19% | 27.64% | -35.82% | 119.24% | Upgrade
|
| Net Cash Per Share | 5.12 | 3.84 | 7.75 | 4.82 | 6.53 | 12.72 | Upgrade
|
| Filing Date Shares Outstanding | 145.98 | 145.98 | 93.5 | 52.23 | 20.35 | 19.95 | Upgrade
|
| Total Common Shares Outstanding | 145.98 | 119.85 | 93.27 | 50.56 | 20.32 | 19.93 | Upgrade
|
| Working Capital | 645.06 | 440.32 | 563.92 | 171.47 | 142.45 | 202.09 | Upgrade
|
| Book Value Per Share | 4.15 | 3.34 | 5.75 | 3.00 | 6.20 | 10.18 | Upgrade
|
| Tangible Book Value | 605.46 | 400.79 | 536.31 | 151.83 | 125.96 | 202.96 | Upgrade
|
| Tangible Book Value Per Share | 4.15 | 3.34 | 5.75 | 3.00 | 6.20 | 10.18 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.